1 |
FOLSTEIN M F, FOLSTEIN S E, MCHUGH P R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician[J]. J Psychiatr Res, 1975, 12(3): 189-198.
|
2 |
WALSH C E, YANG Y C, OI K, et al. Age profiles of cognitive decline and dementia in late life in the aging, demographics, and memory study[J]. J Gerontol B Psychol Sci Soc Sci, 2022, 77(10): 1880-1891.
|
3 |
World Health Organization. World health statistics 2023: monitoring health for the SDGs, sustainable development goals[M]. Geneva: WHO, 2024.
|
4 |
BUFORD T W. Hypertension and aging[J]. Ageing Res Rev, 2016, 26: 96-111.
|
5 |
DUAN J, SAM N B, WANG S J, et al. Exploring the association between cognitive decline and all-cause mortality with blood pressure as a potential modifier in oldest old individuals[J]. Sci Rep, 2022, 12(1): 17108.
|
6 |
HIRANO T. Pathophysiology of diabetic dyslipidemia[J]. J Atheroscler Thromb, 2018, 25(9): 771-782.
|
7 |
IADECOLA C, GOTTESMAN R F. Neurovascular and cognitive dysfunction in hypertension[J]. Circ Res, 2019, 124(7): 1025-1044.
|
8 |
STEWART R A H, HELD C, KRUG-GOURLEY S, et al. Cardiovascular and lifestyle risk factors and cognitive function in patients with stable coronary heart disease[J]. J Am Heart Assoc, 2019, 8(7): e010641.
|
9 |
HAN K T, KIM S J. Are serum cholesterol levels associated with cognitive impairment and depression in elderly individuals without dementia: a retrospective cohort study in South Korea[J]. Int J Geriatr Psychiatry, 2021, 36(1): 163-173.
|
10 |
LESPINASSE J, CHÊNE G, MANGIN J F, et al. Associations among hypertension, dementia biomarkers, and cognition: the MEMENTO cohort[J]. Alzheimers Dement, 2023, 19(6): 2332-2342.
|
11 |
BATTISTA P, SALVATORE C, CASTIGLIONI I. Optimizing neuropsychological assessments for cognitive, behavioral, and functional impairment classification: a machine learning study[J]. Behav Neurol, 2017, 2017: 1850909.
|
12 |
JIA L F, DU Y F, CHU L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study[J]. Lancet Public Health, 2020, 5(12): e661-e671.
|
13 |
刘柯杉, 竹丽萍, 吴晓敏, 等. 天津市社区老年人血脂水平与轻度认知障碍发生关系病例对照研究[J]. 中国公共卫生, 2023, 9(3): 348-352.
|
|
LIU K S, ZHU L P, WU X M, et al. Association of blood lipid levels with mild cognitive impairment in the elderly:community-based case-control study in Tianjin city[J]. Chinese Journal of Public Health, 2023, 9(3): 348-352.
|
14 |
张慧强, 李鹏飞, 郭玉洁, 等. 2017年北京两社区中老年糖尿病患者血脂水平与认知功能关联[J]. 卫生研究, 2022, 51(6): 981-987, 995.
|
|
ZHANG H Q, LIU P F, GUO Y J, et al. Correlation analysis of lipid level and cognitive function in middle-aged and elderly diabetic population from 2 communities in Beijing in 2017[J]. Journal of Hygiene Research, 2022, 51(6): 981-987, 995.
|
15 |
MOONS K G, ALTMAN D G, REITSMA J B, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration[J]. Ann Intern Med, 2015, 162(1): W1-W73.
|
16 |
YANG Z, HOLT H K, FAN J H, et al. Optimal cutoff scores for Alzheimer′s disease using the Chinese version of mini-mental state examination among Chinese population living in rural areas[J]. Am J Alzheimers Dis Other Demen, 2016, 31(8): 650-657.
|
17 |
LIVINGSTON G, HUNTLEY J, SOMMERLAD A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission[J]. Lancet, 2020, 396(10248): 413-446.
|
18 |
DECARLI C. Blood pressure control and cognitive performance: something to think about with aging[J]. JAMA, 2015, 313(19): 1963-1964.
|
19 |
KIM Y J, KWON H K, LEE J M, et al. White matter microstructural changes in pure Alzheimer′s disease and subcortical vascular dementia[J]. Eur J Neurol, 2015, 22(4): 709-716.
|
20 |
MCEVOY L K, FENNEMA-NOTESTINE C, EYLER L T, et al. Hypertension-related alterations in white matter microstructure detectable in middle age[J]. Hypertension, 2015, 66(2): 317-323.
|
21 |
SHAJAHAN S, PETERS R, CARCEL C, et al. Hypertension and mild cognitive impairment: state-of-the-art review[J]. Am J Hypertens, 2024, 37(6): 385-393.
|
22 |
GOTTESMAN R F, SCHNEIDER A L, ALBERT M, et al. Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study[J]. JAMA Neurol, 2014, 71(10): 1218-1227.
|
23 |
VAN DALEN J W, BRAYNE C, CRANE P K, et al. Association of systolic blood pressure with dementia risk and the role of age, U-shaped associations, and mortality[J]. JAMA Intern Med, 2022, 182(2): 142-152.
|
24 |
GAO H, WANG K, AHMADIZAR F, et al. Associations of changes in late-life blood pressure with cognitive impairment among older population in China[J]. BMC Geriatr, 2021, 21(1): 536.
|
25 |
WANG F, LI D, WANG L, et al. Mild hypertension protects the elderly from cognitive impairment: a 7-year retrospective cohort study[J]. Psychogeriatrics, 2020, 20(4): 412-418.
|
26 |
UNGVARI Z, TOTH P, TARANTINI S, et al. Hypertension-induced cognitive impairment: from pathophysiology to public health[J]. Nat Rev Nephrol, 2021, 17(10): 639-654.
|
27 |
VADUGANATHAN M, MENSAH G A, TURCO J V, et al. The global burden of CardiovascularDiseases and risk: a compass for future health[J]. J Am Coll Cardiol, 2022, 80(25): 2361-2371.
|
28 |
FRISARDI V, SOLFRIZZI V, SERIPA D, et al. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer′s disease[J]. Ageing Res Rev, 2010, 9(4): 399-417.
|
29 |
ANCELIN M L, RIPOCHE E, DUPUY A M, et al. Sex differences in the associations between lipid levels and incident dementia[J]. J Alzheimers Dis, 2013, 34(2): 519-528.
|
30 |
LIU Y, ZHONG X, SHEN J J, et al. Elevated serum TC and LDL-C levels in Alzheimer′s disease and mild cognitive impairment: a meta-analysis study[J]. Brain Res, 2020, 1727: 146554.
|
31 |
GUO Y J, LI P F, MA X J, et al. Association of circulating cholesterol level with cognitive function and mild cognitive impairment in the elderly: a community-based population study[J]. Curr Alzheimer Res, 2020, 17(6): 556-565.
|
32 |
ANUSHEEL, AVULA S N, JOSEPH K N, et al. The role of high-density lipoprotein in lowering risk of dementia in the elderly: a review[J]. Cureus, 2022, 14(4): e24374.
|
33 |
SOLOMON A, KIVIPELTO M, WOLOZIN B, et al. Midlife serum cholesterol and increased risk of Alzheimer′s and vascular dementia three decades later[J]. Dement Geriatr Cogn Disord, 2009, 28(1): 75-80.
|
34 |
XU Q, LIN Y, GENG J L, et al. The prevalence and risk factors for cognitive impairment following ischemic stroke[J]. Zhonghua Nei Ke Za Zhi, 2008, 47(12): 981-984.
|
35 |
WANG M Q, LI Y J, CONG L, et al. High-density lipoprotein cholesterol and brain aging amongst rural-dwelling older adults: a population-based magnetic resonance imaging study[J]. Eur J Neurol, 2021, 28(9): 2882-2892.
|
36 |
World Health Organization. Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines[M]. Geneva: World Health Organization; 2019.
|
37 |
DENG Y, ZHAO S Q, CHENG G W, et al. The prevalence of mild cognitive impairment among Chinese people: a meta-analysis[J]. Neuroepidemiology, 2021, 55(2): 79-91.
|
38 |
DE JONG V M T, EIJKEMANS M J C, VAN CALSTER B, et al. Sample size considerations and predictive performance of multinomial logistic prediction models[J]. Stat Med, 2019, 38(9): 1601-1619.
|